Prevoznik Michael E's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Mar 9, 2022
- Accession no.
- 0001022079-22-000060
- Filed
- Mar 9, 2022
- Trade date
- Mar 7-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $842.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prevoznik Michael ECIK 0001222679 | Officer (SVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | Common Stock | AGrant or awardAcquired | +11,544 | $130.09 | +$1,501,758.96 | 50,768 | Direct | |
| Mar 7, 2022 | Common Stock | FTax withholdingDisposed | −5,316 | $130.09 | −$691,558.44 | 45,452 | Direct | |
| Mar 8, 2022 | Common Stock | SSaleDisposed | −6,228 | $135.21 | −$842,087.88 | 39,224 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.